- Home
- EHLD vs CASI Comparison
EHLD vs CASI Comparison
Compare EHLD & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHLD
- CASI
- Stock Information
- Founded
- EHLD 2024
- CASI 1991
- Country
- EHLD Greece
- CASI China
- Employees
- EHLD N/A
- CASI N/A
- Industry
- EHLD
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- EHLD
- CASI Health Care
- Exchange
- EHLD NYSE
- CASI Nasdaq
- Market Cap
- EHLD 17.2M
- CASI 20.5M
- IPO Year
- EHLD N/A
- CASI 1996
- Fundamental
- Price
- EHLD $7.82
- CASI $1.48
- Analyst Decision
- EHLD
- CASI Strong Buy
- Analyst Count
- EHLD 0
- CASI 1
- Target Price
- EHLD N/A
- CASI $4.00
- AVG Volume (30 Days)
- EHLD 14.9K
- CASI 80.5K
- Earning Date
- EHLD 08-15-2025
- CASI 08-15-2025
- Dividend Yield
- EHLD 7.16%
- CASI N/A
- EPS Growth
- EHLD N/A
- CASI N/A
- EPS
- EHLD 4.74
- CASI N/A
- Revenue
- EHLD $14,687,504.00
- CASI $31,368,000.00
- Revenue This Year
- EHLD N/A
- CASI N/A
- Revenue Next Year
- EHLD N/A
- CASI N/A
- P/E Ratio
- EHLD $1.65
- CASI N/A
- Revenue Growth
- EHLD N/A
- CASI 8.39
- 52 Week Low
- EHLD $3.83
- CASI $1.09
- 52 Week High
- EHLD $12.80
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- EHLD N/A
- CASI 54.85
- Support Level
- EHLD N/A
- CASI $1.21
- Resistance Level
- EHLD N/A
- CASI $1.44
- Average True Range (ATR)
- EHLD 0.00
- CASI 0.11
- MACD
- EHLD 0.00
- CASI 0.03
- Stochastic Oscillator
- EHLD 0.00
- CASI 72.97
About EHLD EUROHOLDINGS LTD
Euroholdings Ltd is a provider of shipping transportation services. The company specializes in the ownership of vessels. The fleet of the company consists of containerships that transport container boxes providing scheduled service between ports.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.